🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications ◆
Updated 04 Jul 2026 · HPRA open data

KRKA, d.d., Novo mesto — Licensed Medicines

361 medicines held by KRKA, d.d., Novo mesto on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 361 products held by KRKA, d.d., Novo mesto
MedicineActive substanceLicence holderStatus
Empagliflozin/Metformin Krka 5 mg/850 mg film-coated tablets
PA1347/122/001
 Empagliflozin, Metformin Hydrochloride KRKA, d.d., Novo mesto Not marketed
Emtricitabine/Tenofovir disoproxil Krka 200 mg/245 mg film-coated tablets
EU/1/16/1151/001-004
 Emtricitabine, Tenofovir disoproxil KRKA, d.d., Novo mesto —
Emtricitabine/Tenofovir disoproxil Krka d.d 200 mg/245 mg film-coated tablets
EU/1/17/1182/001-004
 Tenofovir disoproxil, Emtricitabine KRKA, d.d., Novo mesto —
Enalapril/Lercanidipine Krka 10 mg/10 mg film-coated tablets
PA1347/029/001
 Enalapril maleate, Lercanidipine KRKA, d.d., Novo mesto Marketed
Enalapril/Lercanidipine Krka 20 mg/10 mg film-coated tablets
PA1347/029/002
 Enalapril maleate, Lercanidipine KRKA, d.d., Novo mesto Marketed
Enyglid 0.5 mg tablets
EU/1/09/580/1-6
 Repaglinide KRKA, d.d., Novo mesto —
Enyglid 1 mg tablets
EU/1/09/580/7-12
 Repaglinide KRKA, d.d., Novo mesto —
Enyglid 2 mg tablets
EU/1/09/580/13-18
 Repaglinide KRKA, d.d., Novo mesto —
Eplerenone Krka 25 mg film-coated tablets
PA1347/078/001
 Eplerenone KRKA, d.d., Novo mesto Marketed
Eplerenone Krka 50 mg film-coated tablets
PA1347/078/002
 Eplerenone KRKA, d.d., Novo mesto Marketed
ESCADRA 20 mg hard gastro-resistant capsules
PA1347/123/001
 Esomeprazole KRKA, d.d., Novo mesto Not marketed
ESCADRA 40 mg hard gastro-resistant capsules
PA1347/123/002
 Esomeprazole KRKA, d.d., Novo mesto Not marketed
Escitalopram Krka 10 mg film-coated tablets
PA1347/046/002
 Escitalopram oxalate KRKA, d.d., Novo mesto Marketed
Escitalopram Krka 15 mg film-coated tablets
PA1347/046/003
 Escitalopram oxalate KRKA, d.d., Novo mesto Marketed
Escitalopram Krka 20 mg film-coated tablets
PA1347/046/004
 Escitalopram oxalate KRKA, d.d., Novo mesto Marketed
Escitalopram Krka 5 mg film-coated tablets
PA1347/046/001
 Escitalopram oxalate KRKA, d.d., Novo mesto Marketed
Esomeprazole Krka 20 mg hard gastro-resistant capsules
PA1347/017/001
 Esomeprazole KRKA, d.d., Novo mesto Marketed
Esomeprazole Krka 40 mg hard gastro-resistant capsules
PA1347/017/002
 Esomeprazole KRKA, d.d., Novo mesto Marketed
Etoricoxib Krka 120 mg film-coated tablets
PA1347/064/004
 Etoricoxib KRKA, d.d., Novo mesto Marketed
Etoricoxib Krka 30 mg film-coated tablets
PA1347/064/001
 Etoricoxib KRKA, d.d., Novo mesto Marketed
Etoricoxib Krka 60 mg film-coated tablets
PA1347/064/002
 Etoricoxib KRKA, d.d., Novo mesto Marketed
Etoricoxib Krka 90 mg film-coated tablets
PA1347/064/003
 Etoricoxib KRKA, d.d., Novo mesto Marketed
Ezetimibe Krka 10 mg tablets
PA1347/066/001
 Ezetimibe KRKA, d.d., Novo mesto Marketed
Ezetimibe/Atorvastatin Krka 10 mg/10 mg film-coated tablets
PA1347/116/001
 Ezetimibe, Atorvastatin calcium trihydrate KRKA, d.d., Novo mesto Marketed
Ezetimibe/Atorvastatin Krka 10 mg/20 mg film-coated tablets
PA1347/116/002
 Ezetimibe, Atorvastatin calcium trihydrate KRKA, d.d., Novo mesto Marketed
Ezetimibe/Atorvastatin Krka 10 mg/40 mg film-coated tablets
PA1347/116/003
 Ezetimibe, Atorvastatin calcium trihydrate KRKA, d.d., Novo mesto Marketed
Ezetimibe/Atorvastatin Krka 10 mg/80 mg film-coated tablets
PA1347/116/004
 Ezetimibe, Atorvastatin calcium trihydrate KRKA, d.d., Novo mesto Marketed
Ezetimibe/Simvastatin Krka 10 mg/10 mg tablets
PA1347/067/001
 Ezetimibe, Simvastatin KRKA, d.d., Novo mesto Not marketed
Ezetimibe/Simvastatin Krka 10 mg/20 mg tablets
PA1347/067/002
 Ezetimibe, Simvastatin KRKA, d.d., Novo mesto Marketed
Ezetimibe/Simvastatin Krka 10 mg/40 mg tablets
PA1347/067/003
 Ezetimibe, Simvastatin KRKA, d.d., Novo mesto Marketed
Febuxostat Krka 120 mg film-coated tablets
EU/1/18/1347/005-008
 Febuxostat KRKA, d.d., Novo mesto —
Febuxostat Krka 80 mg film-coated tablets
EU/1/18/1347/001-004
 Febuxostat KRKA, d.d., Novo mesto —
Fingolimod Krka 0.5 mg hard capsules
PA1347/101/001
 FINGOLIMOD HYDROCHLORIDE KRKA, d.d., Novo mesto Marketed
Galsya SR 16 mg prolonged-release capsules, hard
PA1347/015/002
 Galantamine KRKA, d.d., Novo mesto Marketed
Galsya SR 24 mg prolonged-release capsules, hard
PA1347/015/003
 Galantamine KRKA, d.d., Novo mesto Marketed
Galsya SR 8 mg prolonged-release capsules, hard
PA1347/015/001
 Galantamine KRKA, d.d., Novo mesto Marketed
Icorvida SR 1.5mg Prolonged-release Tablets
PA1347/022/001
 Indapamide KRKA, d.d., Novo mesto Marketed
Ifirmacombi 150 mg/12.5 mg film-coated tablets
EU/1/11/673/001-008
 Hydrochlorothiazide, Irbesartan KRKA, d.d., Novo mesto —
Ifirmacombi 300 mg/12.5 mg film-coated tablets
EU/1/11/673/009-016
 Hydrochlorothiazide, Irbesartan KRKA, d.d., Novo mesto —
Ifirmacombi 300 mg/25 mg film-coated tablets
EU/1/11/673/017-024
 Hydrochlorothiazide, Irbesartan KRKA, d.d., Novo mesto —
Ifirmasta 150 mg film-coated tablets
EU/1/08/480/7-12
 Irbesartan KRKA, d.d., Novo mesto —
Ifirmasta 300 mg film-coated tablets
EU/1/08/480/13-18
 Irbesartan KRKA, d.d., Novo mesto —
Ifirmasta 75 mg film-coated tablets
EU/1/08/480/1-6
 Irbesartan KRKA, d.d., Novo mesto —
Imatinib Krka d.d 100 mg film-coated tablets
PA1347/054/001
 Imatinib KRKA, d.d., Novo mesto Marketed
Imatinib Krka d.d. 400 mg film-coated tablets
PA1347/054/002
 Imatinib KRKA, d.d., Novo mesto Marketed
Ivabradine Krka 5 mg film-coated tablets
PA1347/065/001
 Ivabradine KRKA, d.d., Novo mesto Marketed
Ivabradine Krka 7.5 mg film-coated tablets
PA1347/065/002
 Ivabradine KRKA, d.d., Novo mesto Marketed
Kamiren 4 mg prolonged-release tablets
PA1347/038/001
 Doxazosin KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 100 mg film-coated tablets
PA1347/099/002
 Lacosamide KRKA, d.d., Novo mesto Marketed
Lacosamide Krka 150 mg film-coated tablets
PA1347/099/003
 Lacosamide KRKA, d.d., Novo mesto Marketed
← 1 2 3 4 5 6 →
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.